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In the recently published work of Juneja and colleagues the 
authors describe the excellent results of a com puterized 
insulin dosing algorithm (Clarian GlucoStabilizer™) [1]. To 
prevent hypoglycemia, however, the authors note that 
frequent (that is, hourly) measurements are required. We 
believe that, with an adequate algorithm, the required 
level of glucose control can be reached without hourly 
glucose measurements.
We implemented the glucose regulation for intensive 
care patients (GRIP) computer-assisted glucose regula-
tion program, which uses time-variant sampling intervals 
[2]. In a recent analysis, hypoglycemia rates were 
comparable with or lower than those described by Juneja 
and colleagues [3]. Most importantly, these rates were 
achieved with only 5.6 measurements per patient per day. 
In all fairness it must be said that GRIP aimed at (and 
achieved) levels of 4.0 to 7.5 mmol/l, which is not as tight 
and challenging as the GlucoStabilizer™ target of 4.4 to 
6.1 mmol/l. Nevertheless, it is our convic tion that an up 
to ﬁ vefold higher glucose sampling rate cannot be 
justiﬁ ed by current evidence on glucose control.
Finally, we would like to note that two main approaches 
for designing computer control of glucose levels exist: 
model predictive control, and proportional-integral deri-
va tive [4]. Th e underlying algorithm of GRIP is not model 
predictive control, as mistakenly stated in the article by 
Juneja and colleagues [1], but proportional-integral 
derivative. In fact, the algorithm of Juneja and colleagues 
also appears to be proportional-integral derivative.
To achieve eﬀ ective and safe computerized glucose 
control, therefore, it is not necessary to perform hourly 
measurements, provided a realistic target and an 
adequate algorithm with a time-variant sampling rate are 
used.
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